Company: DMAAR
Filing Date: 2025-01-22
Form Type: POS AM
Source: 0001213900-25-005176
Chunk: 159

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-22
Form: POS AM
Chunk 159
---
 assets test. If our initial business combination involves more than one target business, the 80% of net assets test will be based on the aggregate value of all of the target businesses. Notwithstanding the foregoing, if we are not then listed on Nasdaq for whatever reason, we would no longer be required to meet the foregoing 80% of net assets test. We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, directors or officers or non -managingsponsor investors. In the event we seek to complete an initial business combination with a target that is affiliated with our sponsor, directors or officers or non -managingsponsor investors, 100 we, or a committee of independent and disinterested directors, may engage independent advisors to assist with the evaluation and would obtain an opinion from an independent investment banking firm or from an independent accounting firm that such an initial business combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context. For additional discussion relating to potential conflicts of interest relating to sourcing of potential business combination targets, see “ Management — Conflicts of Interest.” Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301, and our telephone number is (954) 870 -3099. Following the completion of this offering, our corporate website address will be www.dmaacorp.com. Our website and the information contained on, or that can be accessed through, the website is not deemed to be incorporated by reference in, and is not considered part of, this prospectus or the registration statement of which this prospectus is a part. You should not rely on any such information in making your decision whether to invest in our securities. STATUS AS A PUBLIC COMPANY We believe our structure will make us an attractive business combination partner to target businesses. As an existing public company, we offer target businesses an alternative to the traditional initial public offering through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination. In this situation, the owners of the target business would exchange their capital stock, shares or other equity interests in the target business for our shares or for a combination of our shares and cash, allowing us to tailor the consideration to the specific needs of the sellers. Although there are various costs and obligations associated with being a public company, we believe target businesses will find this method a more certain and cost -effectivem